HealthInvest Small & MicroCap Fund is an actively managed mutual fund which invests in healthcare equities with small market capitalisation. The fund has a global investment focus. The investment strategy is value-based and largely focused on profitable companies in which, for some reason, the share is considered to be under-valued. The overall management goal is to create maximum return while limiting risk. The fund has A and B unit classes.
(As of April 30, 2019)
Small & MicroCap A
50 000 SEK
MSCI World Health Care TRN Index
Small & MicroCap B
MSCI World Health Care TRN Index
Small & MicroCap C
1 000 000 SEK
OMRX T-Bill Index
+ 4 percentage points
Value Fund A
Value Fund B
Value Fund C
* 20% of the return exceeding the annual threshold.
- Fund Rules HealthInvest Small & MicroCap Fund
- Prospectus HealthInvest Small & MicroCap Fund
- Simplified Prospectus HealthInvest Small & MicroCap Fund A
- Simplified Prospectus HealthInvest Small & MicroCap Fund B
- Simplified Prospectus HealthInvest Small & MicroCap Fund C
- Sustainability Information HealthInvest Small & MicroCap
- Addendum for Luxembourg Investors
It is the responsibility of each and every person interested in investing in these funds to ensure that the investment takes place in accordance with applicable laws and other regulations. Foreign law may entail that an investment cannot be made by an investor from outside Sweden. The fund company, HealthInvest Partners AB, has no responsibility whatsoever to verify whether an investment made from outside Sweden takes place in accordance with the laws of the relevant country. The material on this site is directed only at persons in Sweden.
Disputes or claims concerning the fund shall be resolved according to Swedish law and exclusively by Swedish courts of law. There is no guarantee that an investment in a fund managed by HealthInvest Partners cannot result in a loss. This applies irrespective of otherwise positive performance on the financial markets. Past performance is no guarantee of future results.
Information from the fund company shall not be considered a recommendation to invest in the Funds. Every person considering purchasing units in any of the Funds must make an independent assessment of such an investment and the risks associated therewith. Investments in the Funds should be seen as long-term investments.
The Funds’ prospectuses and other information about the Funds are avaliable online at www.healthinvest.se. You can also receive this information at no cost by calling +46 80 440 38 30 or by sending an e-mail request to firstname.lastname@example.org.
If you would like to contact HealthInvest Partners regarding a complaint, please contact Johan Stern. Any complaints should be submitted to the fund company in writing, and are always free of charge. Investors will receive a response as soon as possible.
You may also obtain further guidance from the Swedish Consumers´ Banking & Finance Bureau and the Swedish Consumers Insurance Bureau, as well as through the local consumer advisor. There is also the possibility to adjudicate disputes legally at the Swedish National Board for Consumer Disputes or in courts of general jurisdiction.
HealthInvest Partners’ information regarding complaints is available upon request.